NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954,650 | -9.1% | 21,574 | 0.0% | 0.04% | -15.1% |
| Q2 2023 | $1,049,791 | -12.4% | 21,574 | 0.0% | 0.05% | -7.0% |
| Q1 2023 | $1,197,788 | +38.2% | 21,574 | 0.0% | 0.06% | +9.6% |
| Q4 2022 | $866,628 | -8.3% | 21,574 | 0.0% | 0.05% | -17.5% |
| Q3 2022 | $945,000 | +14.7% | 21,574 | -7.2% | 0.06% | +26.0% |
| Q2 2022 | $824,000 | -12.9% | 23,243 | 0.0% | 0.05% | +6.4% |
| Q1 2022 | $946,000 | -56.4% | 23,243 | 0.0% | 0.05% | -42.0% |
| Q4 2021 | $2,171,000 | -9.7% | 23,243 | +7.7% | 0.08% | -24.3% |
| Q3 2021 | $2,404,000 | -1.8% | 21,574 | 0.0% | 0.11% | -12.3% |
| Q2 2021 | $2,449,000 | +11.8% | 21,574 | 0.0% | 0.12% | +20.8% |
| Q1 2021 | $2,191,000 | +2.0% | 21,574 | 0.0% | 0.10% | +6.3% |
| Q4 2020 | $2,147,000 | +37.7% | 21,574 | 0.0% | 0.10% | +5.6% |
| Q3 2020 | $1,559,000 | +44.9% | 21,574 | 0.0% | 0.09% | +21.6% |
| Q2 2020 | $1,076,000 | +67.1% | 21,574 | 0.0% | 0.07% | +45.1% |
| Q1 2020 | $644,000 | -11.4% | 21,574 | 0.0% | 0.05% | +6.2% |
| Q4 2019 | $727,000 | +2.7% | 21,574 | 0.0% | 0.05% | +29.7% |
| Q3 2019 | $708,000 | +19.0% | 21,574 | 0.0% | 0.04% | +54.2% |
| Q2 2019 | $595,000 | +33.7% | 21,574 | 0.0% | 0.02% | +26.3% |
| Q1 2019 | $445,000 | +47.8% | 21,574 | 0.0% | 0.02% | +5.6% |
| Q4 2018 | $301,000 | -41.7% | 21,574 | 0.0% | 0.02% | -35.7% |
| Q3 2018 | $516,000 | +27.1% | 21,574 | 0.0% | 0.03% | -12.5% |
| Q2 2018 | $406,000 | +103.0% | 21,574 | 0.0% | 0.03% | +166.7% |
| Q1 2018 | $200,000 | +3.1% | 21,574 | 0.0% | 0.01% | -7.7% |
| Q4 2017 | $194,000 | -30.2% | 21,574 | 0.0% | 0.01% | -7.1% |
| Q3 2017 | $278,000 | +18.8% | 21,574 | 0.0% | 0.01% | +7.7% |
| Q2 2017 | $234,000 | +22.5% | 21,574 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $191,000 | -24.5% | 21,574 | 0.0% | 0.01% | -27.8% |
| Q4 2016 | $253,000 | +5.4% | 21,574 | 0.0% | 0.02% | +20.0% |
| Q3 2016 | $240,000 | -38.3% | 21,574 | -33.1% | 0.02% | -44.4% |
| Q2 2016 | $389,000 | – | 32,243 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |